Navigation Links
Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis
Date:10/16/2010

EAST HANOVER, N.J., Oct. 16 /PRNewswire/ -- Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast® (zoledronic acid) injection in postmenopausal women with osteoporosis.(1) The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

The study showed that Reclast maintained bone mass in postmenopausal osteoporotic patients who received annual infusions for six years.(1) In patients who stopped Reclast treatment after three years, the bone mineral density (BMD) decreased significantly but remained well above the levels measured at the beginning of the study (difference between the two groups at six years: 1.04%, p-value = 0.0009).(1)

Patients who stayed on Reclast therapy for six years reduced their risk of new morphometric spine fractures by 52%, compared to those who stopped treatment at three years (p-value = 0.04).(1) Morphometric fractures can occur unaccompanied by pain and therefore may not be diagnosed and treated; they can be felt or seen over time in the form of back pain, loss of height, or stooped posture.(4)

"These new findings show that continued treatment with zoledronic acid for six years continues to maintain bone mass and reduce vertebral fractures risk with no change to its favorable safety profile compared to discontinuation of treatment after three years," said Dennis Black, PhD, the study's lead author and Professor of Epidemiology and Biostatistics at the University of California, San Francisco.  "These new long-term data reconfirm Reclast as an important therapeutic option for doctors when considering osteoporosis treatment for their patients."

In both study groups, the bone markers were maintained over six years within the normal premenopausal range.(1) In patients who discontinued Reclast after three years, there was no evid
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
2. Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management
3. NCPA Announces New Division Dedicated to Long-Term Care Pharmacies, Patients
4. Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy
5. Long-Term Data Show Advantages for TAXUS® Liberte® Stent in Small Vessels and Long Lesions
6. New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years
7. Study of Long-Term Efficacy and Safety of New PyratineXR™ Moisturizing Lotion Featured in Journal of Drugs in Dermatology
8. Partnership for Quality Medical Donations Commits to Long-Term Recovery in Haiti
9. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
10. FIRMAGON® Results in Fast, Long-Term Suppression of Testosterone in Prostate Cancer Patients Without Initial Testosterone Surge
11. FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , February 26, 2015 ... Outlook 2015: First -In- Class Innovations and Cost ... for Large Cap Pharmaceutical Companies research report to ... According to this Global Pharma US & ... as productivity measurements, divestment of non-core assets result ...
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank ... therapeutics for the treatment of Hepatitis B virus ... closing of a $22 million financing. Funds from ... 9200, a novel, broad spectrum antiviral agent derived ... acid hybrid (SMNH) chemistry platform, into Phase II ...
(Date:2/26/2015)... 26, 2015 Integrity Applications, Inc. (OTCQB: IGAP) ... model DF-F, a noninvasive  device that tracks blood glucose ... Ph.D., will head its new scientific advisory board that ... field of Diabetes research, monitoring and treatment. ... Chief Executive Officer and Head, Business Development of Profil ...
Breaking Medicine Technology:Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4Spring Bank Pharmaceuticals Completes $22 Million Financing 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4
... , , ... Remedies announced today that its NutraRx brand of natural ... country to receive the Emerson EQP Seal in recognition of the ... "After a rigorous evaluation by Emerson Ecologics of our NutraRx brand ...
... ALBUQUERQUE, N.M. , Feb. 16 ... develops and markets proprietary genomic tests, today announced an ... promote its diagnostic services to gastroenterologists throughout the ... gastroenterology-focused sales force will introduce Exagen,s proprietary gene expression ...
Cached Medicine Technology:Native Remedies' NutraRx Brand of Natural Products for Medical Practitioners Among First to Earn Prestigious 'Emerson EQP Seal' 2Native Remedies' NutraRx Brand of Natural Products for Medical Practitioners Among First to Earn Prestigious 'Emerson EQP Seal' 3Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice 2
(Date:2/27/2015)... Local lice removal service reports that cases of ... of Pinecrest, Key Biscayne, Coral Gables, Miami Beach and Aventura, ... to isolate and eradicate the problem. , Among tweens ... be partly to blame. As kids put their heads together ... that can allow for the spread of head lice. According ...
(Date:2/27/2015)... 2015 RDI-Engineering will be hosting an ... event on March 14, at Moreno Valley College. The ... how to use engineering software and tools, and a ... by Moreno Valley College’s Upward Bound Math and Science ... in hopes to encourage students to seek educational and ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Prescription ... the U.S. Drug Enforcement Agency (DEA). Today, ... organizations continue to utilize the “Take-Back” guidelines for ... the FDA. , Eufaula Prescription Drug Disposal Event ... Industrial Drive in Eufaula, Oklahoma as the “Take-Back” ...
(Date:2/27/2015)... CO (PRWEB) February 27, 2015 Philanthropy is ... Kevin and Amy Smits help to restore that faith ... the last six years, this husband/wife Realtor team gives to ... charities have remained the same while others have been added ... Assault provides a safe haven and counseling for women ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Educators ... California Teachers of the Year. The gala recognized the ... their students achieve both in and outside of the ... instructor at Manhattan Beach Middle School, was nominated as ... As the Presenting Sponsor of the California Department of ...
Breaking Medicine News(10 mins):Health News:Parents frustrated as selfies continue to contribute to the spread of head lice in Miami according to the largest Lice Removal Service in Miami called Lice Troopers 2Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2Health News:California Casualty is Presenting Sponsor of California Program Honoring Educators That Make a Difference 2Health News:California Casualty is Presenting Sponsor of California Program Honoring Educators That Make a Difference 3
... three receptors could help doctors predict the likely survival ... the open access journal Breast Cancer Research shows that ... (ER), progesterone receptor (PR) and human epidermal growth receptor-2 ... at risk from developing brain metastases. Survival is also ...
... St. Jude Children,s,Research Hospital(R) and Stanford Financial Group announced ... the 2008 Eagles for St.,Jude program. Villegas has pledged ... makes on the 2008 PGA TOUR. Earlier this year, ... on the TOUR this season, and he,donated $50,000 to ...
... Department of Family Medicine, with support from the Robert Wood ... Health and Healthcare, a group that will study health care ... The network will also mentor and develop a new generation ... , The new group to be directed ...
... vasopressin might be slightly better than norepinephrine in less ... The artery-tightening medication vasopressin holds no overall advantage over ... septic shock, a new study finds. , But vasopressin ... in the study, said Dr. James. A Russell, a ...
... Feb. 27 Cryo-Cell,International Inc. (OTC Bulletin Board: CCEL) ... of Stockholders on July 15, 2008. The record,date for ... announced, a,special meeting of stockholders to elect directors will ... not constitute the Company,s annual meeting., The Company ...
... N.J., Feb. 27 The Healthcare,Businesswomen,s Association (HBA) ... as the 2008 Honorable Mentor. Kanavy,is the HBA,s ... at the,19th annual HBA "Woman of the Year" ... York Hilton., "Genentech is committed to the ...
Cached Medicine News:Health News:Breast cancer subtypes linked to survival from secondary brain tumors 2Health News:Camilo Villegas Joins Vijay Singh in Supporting 'Eagles for St. Jude' Program 2Health News:Camilo Villegas Joins Vijay Singh in Supporting 'Eagles for St. Jude' Program 3Health News:UCLA launches network to study health care disparities affecting minorities 2Health News:Two Drugs Found Equal in Treatment of Septic Shock 2Health News:Cryo-Cell International to Hold 2008 Annual Meeting on July 15, 2008 2Health News:Healthcare Businesswomen's Association Names Genentech's Leonard Kanavy, Vice President, Commercial Operations as the 2008 Honorable Mentor 2Health News:Healthcare Businesswomen's Association Names Genentech's Leonard Kanavy, Vice President, Commercial Operations as the 2008 Honorable Mentor 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: